SBC Medical

Q2 FY2026 EarningsSBC Q2 FY26 results presented a mixed performance against consensus: total revenue of $49M beat the $45.45M expected by 7.82%, driven by successful fee increases and AI-enabled service enhancements. However, Normalized EPS of $0.10 missed the $0.1175 consensus. Despite the bottom-line miss, the company showed significant recovery momentum with Net Income up 335% YoY and a healthy 41% Adjusted EBITDA margin. Management’s successful restructuring and focus on AI-driven platform scalability suggest a strengthening growth trajectory.